Athira Pharma(US:ATHA) Benzinga·2025-12-18 14:47Market Performance - U.S. stocks experienced a positive trading session, with the Dow Jones index increasing by approximately 400 points, up 0.84% to 48,289.58, while the NASDAQ rose 1.53% to 23,040.25, and the S&P 500 gained 1.09% to 6,794.36 [1] - Consumer discretionary shares increased by 1.6%, while energy stocks fell by 0.8% [1] Company Earnings - Accenture reported first-quarter 2026 earnings of $3.94 per share, exceeding the analyst consensus estimate of $3.75, and sales of $18.700 billion, slightly above the consensus estimate of $18.523 billion [2] Commodity Prices - Oil prices rose by 1% to $56.48, while gold prices decreased by 0.2% to $4,364.50. Silver fell by 1.1% to $66.160, and copper increased by 0.1% to $5.4370 [5] European Market Performance - European shares showed gains, with the eurozone's STOXX 600 up 0.5%, Spain's IBEX 35 Index rising 0.7%, London's FTSE 100 gaining 0.1%, Germany's DAX 40 increasing by 0.5%, and France's CAC 40 up 0.4% [6] Asian Market Performance - Asian markets closed mixed, with Japan's Nikkei down 1.03%, Hong Kong's Hang Seng up 0.12%, China's Shanghai Composite rising 0.16%, and India's BSE Sensex falling 0.09% [7] Stock Movements - Athira Pharma Inc shares surged 88% to $7.76 following an agreement to acquire rights for lasofoxifene development. Sable Offshore Corp shares increased by 58% to $8.36, and FuelCell Energy Inc shares rose by 32% to $10.39 after reporting better-than-expected fourth-quarter results [9] - Conversely, Mega Fortune Co Ltd shares dropped 59% to $5.34, and Pyxis Oncology Inc shares fell 54% to $1.56 after announcing preliminary data from clinical studies. Actelis Networks Inc shares decreased by 45% to $0.60 following a public offering announcement [9]